Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations

Andréia Maria da Silva Fonseca, Jaqueline de Azevedo Silva, João Alexandre Trés Pancotto, Eduardo Antônio Donadi, Ludovica Segat, Sergio Crovella, Paula Sandrin-Garcia

Research output: Contribution to journalArticlepeer-review


Systemic lupus erythematosus (SLE) is an autoimmune disorder with several clinical manifestations. SLE etiology has a strong genetic component, which plays a key role in disease's predisposition, as well as participation of environmental factors, such and UV light exposure. In this regard, we investigated whether polymorphisms in STK17A, a DNA repair related gene, encoding for serine/threonine-protein kinase 17A, are associated with SLE susceptibility. A total of 143 SLE patients and 177 healthy controls from Southern Brazil were genotyped for five STK17A TagSNPs. Our results indicated association of rs7805969 SNP (A and G/A genotype, OR = 1.40 and OR = 1.73, respectively) with SLE predisposition and the following clinical manifestations: arthritis, cutaneous and immunological alterations. When analyzing haplotypes distribution, we found association between TGGTC, TAGTC and AAGAT haplotypes and risk to develop SLE. When considering clinical manifestations, the haplotypes TGGTT and TAGTC were associated with protection against cutaneous alterations and the haplotype TAGTC to hematological alterations. We also observed association between SLE clinical manifestations and ethnicity, with the European-derived patients being more susceptible to cutaneous and hematological alterations.

Original languageEnglish
Pages (from-to)435-439
Number of pages5
Issue number2
Publication statusPublished - Sep 25 2013


  • Serine/threonine protein kinase 17A
  • Single nucleotide polymorphisms
  • STK17A
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations'. Together they form a unique fingerprint.

Cite this